Excessive Blood Tests Could Raise Heart Surgery Morbidity

This article originally appeared here.
Share this content:
Excessive Blood Tests Could Raise Heart Surgery Morbidity
Excessive Blood Tests Could Raise Heart Surgery Morbidity

MONDAY, March 2, 2015 (HealthDay News) -- The high number of blood tests done before and after heart surgery can sometimes lead to excessive blood loss, possibly causing anemia and the need for a blood transfusion, new research suggests. Results of the study were published in the March issue of The Annals of Thoracic Surgery.

The study included 1,894 patients who had heart surgery at the Cleveland Clinic between January 2012 and June 2012. From the time they first met their heart surgeons until they left the hospital, the patients collectively had 221,498 blood tests. That works out to 116 tests per patient, according to the study. The total median amount of blood gathered during an entire hospital stay was about 15 ounces (454 milliliters) per patient, the researchers found.

"We were astonished by the amount of blood taken from our patients for laboratory testing. Total phlebotomy volumes approached 1 to 2 units of red blood cells, which is roughly equivalent to one to two cans of soda," study leader Colleen Koch, M.D., of the Cleveland Clinic, said in a journal news release. The highest amounts of blood loss occurred among patients undergoing the most complex heart surgeries. The greater the number of lab tests and the longer patients stayed in the hospital, the more likely they were to require transfusions.

"Prior research shows that patients who receive blood transfusions during heart surgery have more infections after surgery, spend more time on the ventilator, and die more frequently -- even after adjusting for how sick they were prior to surgery," Koch said. "Every attempt should be made to conserve the patient's own blood -- every drop of blood counts."

Abstract
Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions



Sign up for myCME e-newsletters




More in Home

FDA Approves Palynziq for Phenylketonuria

FDA Approves Palynziq for Phenylketonuria

Drug is a novel enzyme therapy for adult patients with PKU with uncontrolled blood Phe concentrations

Increase in Tx Candidates With 2017 Hypertension Guidelines

Increase in Tx Candidates With 2017 Hypertension Guidelines

Increase in proportion of adults recommended for treatment; estimated decrease in CVD events, deaths